Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis.

Capo V, Penna S, Merelli I, Barcella M, Scala S, Basso-Ricci L, Draghici E, Palagano E, Zonari E, Desantis G, Uva P, Cusano R, Sergi Sergi L, Crisafulli L, Moshous D, Stepensky P, Drabko K, Kaya Z, Unal E, Gezdirici A, Menna G, Serafini M, Aiuti A, Locatelli SL, Carlo-Stella C, Schulz AS, Ficara F, Sobacchi C, Gentner B, Villa A.

Haematologica. 2020 Jan 16. pii: haematol.2019.238261. doi: 10.3324/haematol.2019.238261. [Epub ahead of print]

2.

Generation of an immunodeficient mouse model of tcirg1-deficient autosomal recessive osteopetrosis.

Palagano E, Muggeo S, Crisafulli L, Tourkova IL, Strina D, Mantero S, Fontana E, Locatelli SL, Monari M, Morenghi E, Carlo-Stella C, Barnett JB, Blair HC, Vezzoni P, Villa A, Sobacchi C, Ficara F.

Bone Rep. 2020 Jan 7;12:100242. doi: 10.1016/j.bonr.2020.100242. eCollection 2020 Jun.

3.

Chromosome Transplantation: Correction of the Chronic Granulomatous Disease Defect in Mouse Induced Pluripotent Stem Cells.

Castelli A, Susani L, Menale C, Muggeo S, Caldana E, Strina D, Cassani B, Recordati C, Scanziani E, Ficara F, Villa A, Vezzoni P, Paulis M.

Stem Cells. 2019 Jul;37(7):876-887. doi: 10.1002/stem.3006. Epub 2019 Apr 2.

PMID:
30895693
4.

MicroRNA-127-3p controls murine hematopoietic stem cell maintenance by limiting differentiation.

Crisafulli L, Muggeo S, Uva P, Wang Y, Iwasaki M, Locatelli S, Anselmo A, Colombo FS, Carlo-Stella C, Cleary ML, Villa A, Gentner B, Ficara F.

Haematologica. 2019 Sep;104(9):1744-1755. doi: 10.3324/haematol.2018.198499. Epub 2019 Feb 21.

5.

ACKR2 in hematopoietic precursors as a checkpoint of neutrophil release and anti-metastatic activity.

Massara M, Bonavita O, Savino B, Caronni N, Mollica Poeta V, Sironi M, Setten E, Recordati C, Crisafulli L, Ficara F, Mantovani A, Locati M, Bonecchi R.

Nat Commun. 2018 Feb 14;9(1):676. doi: 10.1038/s41467-018-03080-8.

6.

Fusion between cancer cells and macrophages occurs in a murine model of spontaneous neu+ breast cancer without increasing its metastatic potential.

Lizier M, Anselmo A, Mantero S, Ficara F, Paulis M, Vezzoni P, Lucchini F, Pacchiana G.

Oncotarget. 2016 Sep 20;7(38):60793-60806. doi: 10.18632/oncotarget.11508.

7.

Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts.

Neri T, Muggeo S, Paulis M, Caldana ME, Crisafulli L, Strina D, Focarelli ML, Faggioli F, Recordati C, Scaramuzza S, Scanziani E, Mantero S, Buracchi C, Sobacchi C, Lombardo A, Naldini L, Vezzoni P, Villa A, Ficara F.

Stem Cell Reports. 2015 Oct 13;5(4):558-68. doi: 10.1016/j.stemcr.2015.08.005. Epub 2015 Sep 3.

8.

MLL becomes functional through intra-molecular interaction not by proteolytic processing.

Yokoyama A, Ficara F, Murphy MJ, Meisel C, Hatanaka C, Kitabayashi I, Cleary ML.

PLoS One. 2013 Sep 10;8(9):e73649. doi: 10.1371/journal.pone.0073649. eCollection 2013.

9.

Pbx1 restrains myeloid maturation while preserving lymphoid potential in hematopoietic progenitors.

Ficara F, Crisafulli L, Lin C, Iwasaki M, Smith KS, Zammataro L, Cleary ML.

J Cell Sci. 2013 Jul 15;126(Pt 14):3181-91. doi: 10.1242/jcs.125435. Epub 2013 May 9.

10.

Osteopetrosis rescue upon RANKL administration to Rankl(-/-) mice: a new therapy for human RANKL-dependent ARO.

Lo Iacono N, Blair HC, Poliani PL, Marrella V, Ficara F, Cassani B, Facchetti F, Fontana E, Guerrini MM, Traggiai E, Schena F, Paulis M, Mantero S, Inforzato A, Valaperta S, Pangrazio A, Crisafulli L, Maina V, Kostenuik P, Vezzoni P, Villa A, Sobacchi C.

J Bone Miner Res. 2012 Dec;27(12):2501-10. doi: 10.1002/jbmr.1712.

11.

Anti-CD3ε mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome: therapeutic implications.

Marrella V, Poliani PL, Fontana E, Casati A, Maina V, Cassani B, Ficara F, Cominelli M, Schena F, Paulis M, Traggiai E, Vezzoni P, Grassi F, Villa A.

Blood. 2012 Aug 2;120(5):1005-14. doi: 10.1182/blood-2012-01-406827. Epub 2012 Jun 21.

12.

Proteolytically cleaved MLL subunits are susceptible to distinct degradation pathways.

Yokoyama A, Ficara F, Murphy MJ, Meisel C, Naresh A, Kitabayashi I, Cleary ML.

J Cell Sci. 2011 Jul 1;124(Pt 13):2208-19. doi: 10.1242/jcs.080523.

13.

GSK-3 promotes conditional association of CREB and its coactivators with MEIS1 to facilitate HOX-mediated transcription and oncogenesis.

Wang Z, Iwasaki M, Ficara F, Lin C, Matheny C, Wong SH, Smith KS, Cleary ML.

Cancer Cell. 2010 Jun 15;17(6):597-608. doi: 10.1016/j.ccr.2010.04.024.

14.

The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression.

Wong P, Iwasaki M, Somervaille TC, Ficara F, Carico C, Arnold C, Chen CZ, Cleary ML.

Cancer Res. 2010 May 1;70(9):3833-42. doi: 10.1158/0008-5472.CAN-09-3268. Epub 2010 Apr 20.

15.

Pbx1 regulates self-renewal of long-term hematopoietic stem cells by maintaining their quiescence.

Ficara F, Murphy MJ, Lin M, Cleary ML.

Cell Stem Cell. 2008 May 8;2(5):484-96. doi: 10.1016/j.stem.2008.03.004.

16.

Molecular purging of multiple myeloma cells by ex-vivo culture and retroviral transduction of mobilized-blood CD34+ cells.

Deola S, Scaramuzza S, Birolo RS, Cergnul M, Ficara F, Dando J, Voena C, Vai S, Monari M, Pogliani E, Corneo G, Peccatori J, Selleri S, Bordignon C, Roncarolo MG, Aiuti A, Bregni M.

J Transl Med. 2007 Jul 12;5:35.

17.

Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients.

Ricca I, Rocci A, Drandi D, Francese R, Compagno M, Lobetti Bodoni C, De Marco F, Astolfi M, Monitillo L, Vallet S, Calvi R, Ficara F, Omedè P, Rosato R, Gallamini A, Marinone C, Bergui L, Boccadoro M, Tarella C, Ladetto M.

Leukemia. 2007 Apr;21(4):697-705. Epub 2007 Feb 15.

PMID:
17301820
18.

IL-3 or IL-7 increases ex vivo gene transfer efficiency in ADA-SCID BM CD34+ cells while maintaining in vivo lymphoid potential.

Ficara F, Superchi DB, Hernández RJ, Mocchetti C, Carballido-Perrig N, Andolfi G, Deola S, Colombo A, Bordignon C, Carballido JM, Roncarolo MG, Aiuti A.

Mol Ther. 2004 Dec;10(6):1096-108.

19.
20.

Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-Hu mice.

Deola S, Scaramuzza S, Birolo RS, Carballido-Perrig N, Ficara F, Mocchetti C, Dando J, Carballido JM, Bordignon C, Roncarolo MG, Bregni M, Aiuti A.

Hum Gene Ther. 2004 Mar;15(3):305-11.

PMID:
15018739
21.

Gene therapy for adenosine deaminase deficiency.

Aiuti A, Ficara F, Cattaneo F, Bordignon C, Roncarolo MG.

Curr Opin Allergy Clin Immunol. 2003 Dec;3(6):461-6. Review.

PMID:
14612670
22.

A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation.

Zino E, Frumento G, Marktel S, Sormani MP, Ficara F, Di Terlizzi S, Parodi AM, Sergeant R, Martinetti M, Bontadini A, Bonifazi F, Lisini D, Mazzi B, Rossini S, Servida P, Ciceri F, Bonini C, Lanino E, Bandini G, Locatelli F, Apperley J, Bacigalupo A, Ferrara GB, Bordignon C, Fleischhauer K.

Blood. 2004 Feb 15;103(4):1417-24. Epub 2003 Oct 23.

PMID:
14576061
23.

Developmental expression of the T-box transcription factor T-bet/Tbx21 during mouse embryogenesis.

Faedo A, Ficara F, Ghiani M, Aiuti A, Rubenstein JL, Bulfone A.

Mech Dev. 2002 Aug;116(1-2):157-60.

24.

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.

Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortellaro A, Morecki S, Andolfi G, Tabucchi A, Carlucci F, Marinello E, Cattaneo F, Vai S, Servida P, Miniero R, Roncarolo MG, Bordignon C.

Science. 2002 Jun 28;296(5577):2410-3.

25.

Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement.

Aiuti A, Vai S, Mortellaro A, Casorati G, Ficara F, Andolfi G, Ferrari G, Tabucchi A, Carlucci F, Ochs HD, Notarangelo LD, Roncarolo MG, Bordignon C.

Nat Med. 2002 May;8(5):423-5. No abstract available.

PMID:
11984564
26.

Optimisation of retroviral supernatant production conditions for the genetic modification of human CD34+ cells.

Dando JS, Aiuti A, Deola S, Ficara F, Bordignon C.

J Gene Med. 2001 May-Jun;3(3):219-27.

PMID:
11437327
27.

Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy.

Isgrò A, Mezzaroma I, Aiuti A, De Vita L, Franchi F, Pandolfi F, Alario C, Ficara F, Riva E, Antonelli G, Aiuti F.

AIDS Res Hum Retroviruses. 2000 Oct 10;16(15):1471-9.

PMID:
11054260
28.

Expression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lympho-hematopoietic progenitors.

Aiuti A, Tavian M, Cipponi A, Ficara F, Zappone E, Hoxie J, Peault B, Bordignon C.

Eur J Immunol. 1999 Jun;29(6):1823-31.

29.

Quantitative expression of HLA class I molecules in acute non-lymphoblastic leukaemia cells.

D'Alfonso S, Savoia P, Pitti G, Peruccio D, Pozzi C, Crepaldi T, Falda M, Ficara F, Resegotti L, Momigliano Richiardi P.

Eur J Immunogenet. 1993 Jun;20(3):165-73.

PMID:
8338814
30.

Serum erythropoietin level and marrow erythroid infiltration predict response to recombinant human erythropoietin in myelodysplastic syndromes.

Depaoli L, Levis A, Isabella N, Ficara F, Priotto C, Lista P, Foà R, Resegotti L.

Haematologica. 1993 Mar-Apr;78(2):118-22.

PMID:
8349187
31.

Evaluation of bone marrow cellularity by magnetic resonance imaging in patients with myelodysplastic syndrome.

Depaoli L, Davini O, Foggetti MD, Ficara F, Priotto C, Cirillo R, Resegotti L.

Eur J Haematol. 1992 Aug;49(2):105-7.

PMID:
1397236
32.

Prognostic significance of serum albumin in chronic lymphocytic leukemia.

Levis A, Ficara F, Marmont F, De Crescenzo A, Resegotti L.

Haematologica. 1991 Mar-Apr;76(2):113-9.

PMID:
1937168
33.

[Significance and independence of the immunologic, histological, and clinical features as prognostic factors in chronic lymphatic leukemia].

Resegotti L, Levis A, Decrescenzo A, Ficara F, Pini M.

Haematologica. 1989 Oct;74(5 Suppl):368-79. Italian. No abstract available.

PMID:
2512221

Supplemental Content

Loading ...
Support Center